Although the enzymatic pre-treatment did not allow to discriminate between the complex and the free form, and any tumor-specific bikunin isoform was evidenced, they were able to identify plasma bikunin as a strong and independent favorable prognostic marker for ovarian cancer. The gene discussed is AMBP; the disease is ovarian carcinoma.